Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
In Vitro and In Vivo Models of Multiple Sclerosis.
Multiple sclerosis: Risk factors for progressive multifocal leukoencephalopathy identified in natalizumab-treated patients.
Role of T cells in neuromyelitis optica.
Functional MRI Examination of Visual Pathways in Patients with Unilateral Optic Neuritis.
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.
Cervical dysplasia associated with the use of natalizumab.
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Multiple Sclerosis Patients.
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
On the Epidemiology of Multiple Sclerosis in the Middle East and North Africa.
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.
T Cell Apoptosis and Induction of Foxp3+ Regulatory T Cells Underlie the Therapeutic Efficacy of CD4 Blockade in Experimental Autoimmune Encephalomyelitis.
Persistence of Epstein-Barr Virus in Self-reactive Memory B Cells.
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
Anorexia heralding the onset of neuromyelitis optica.
Mechanics in Neuronal Development and Repair.
Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
The grey matter correlates of impaired decision-making in multiple sclerosis.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.
Pages
« first
‹ previous
…
224
225
226
227
228
229
230
231
232
…
next ›
last »